drugset / Trial / NCT02500485
The Drug-drug Interaction of SHR3824 and SP2086
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to investigate the potential interaction between multiple oral doses of SHR3824 and multiple oral doses of SP2086 in healthy adult volunteers.
Timeline
- Start
- 2015-05
- Primary completion
- 2015-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Henagliflozin | Small molecule | 20 mg | Oral |
| Subject | Retagliptin | Small molecule | 100 mg | Oral |